The confused puzzles in antineutrophil cytoplasmic antibody‐associated vasculitis activity evaluation: A case report

• Main Authors: Ai‐hua Zhang, Wei‐long Yao, Wen‐hu Liu
• Format: Article
• Language: English
• Published: Wiley 2021-07-01
• Series: Clinical Case Reports
• Subjects: adverse effect; ANCA‐associated vasculitis; disease activity; immunosuppressive therapy; infection; mucormycosis
• Online Access: https://doi.org/10.1002/ccr3.4497

Abstract Antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is a group of chronic multisystem autoimmune diseases with substantial mortality and morbidity and frequent relapses. The complexity of the disease condition and treatment‐related adverse reactions as well as infections play important roles in the poor outcomes. Unfortunately, the subjective symptoms and objective indicators are not fully parallel, and manifestations between disease activity and treatment‐related adverse reactions are often similar. Here, we describe a case of pulmonary mucormycosis in an old female patient with AAV to highlight these challenges.